Tesaro Turns to Public Markets for Next 12 Months' Cash
By Catherine Shaffer
Friday, February 22, 2013
Tesaro Inc. topped up its cash with a $75 million public offering to support development and clinical trials of its oncology pipeline products. The company expects net proceeds of $69.7 million to support operations for the next 12 months.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.